TEVA

TEVA PHARMACEUTICAL-SP ADR

TEVA·881624209·US·ADR·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G

TEVA (TEVA PHARMACEUTICAL-SP ADR) is held by 243 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($2.2B), Phoenix Financial Ltd. ($1.5B), WCM INVESTMENT MANAGEMENT, LLC ($1.4B). Net institutional sentiment: Mixed.

243
Holders
(20 Elite)
$16B
Total Value
64% (245)
Consensus
157 buying - 88 selling
13F: Insider & Congress: Updated regularly
TEVA

Smart Money Verdict

View all
Loading verdict
Held by 243 funds
20 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Aug 25, 2026 · Activists Feb 17, 2026 · Congress none

InsiderWAWeiss AmirSell $261KAug 21, 2026
InsiderSRSatchi-Fainaro RonitSell $15KAug 21, 2026
InsiderWAWeiss AmirExercise 3K shAug 21, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
63.9M(-1.9%)$2.2B0.0%+65.55%
0
Increased
42.9M(+0.4%)$1.5B9.9%+126.44%
62
Increased
41.3M(+1.2%)$1.4B2.5%+18.86%
55
Increased
39.9M(+0.6%)$1.4B5.3%+217.42%
62
Decreased
30.3M(-8.7%)$1B0.0%+53.53%
0
Increased
18.9M(+6.4%)$641.6M0.0%+179.41%
34
Increased
12.5M(+41.9%)$424.7M0.1%+16.41%
42
Increased
11.6M(+9.9%)$391M0.0%+149.76%
34
Increased
8M(+4.2%)$269.6M0.0%+71.67%
32
Increased
7.7M(+5.8%)$259.9M0.0%+82.68%
33
Decreased
7M(-6.2%)$236.1M0.0%+87.55%
0
Increased
7M(+3.2%)$232.5M0.0%+24.63%
32
Increased
6.6M(+362.5%)$223.4M0.7%+13.08%
70
Increased
6.3M(+13.4%)$212M0.5%+64.51%
49
Increased
6.1M(+27.0%)$207.7M0.0%+54.58%
38
Increased
5.2M(+0.7%)$176.6M0.4%+72.05%
37
Decreased
5.1M(-23.7%)$172.1M3.1%+156.13%
0
Increased
4.2M(+6.8%)$143.2M0.0%+93.92%
32
Decreased
4.1M(-2.5%)$139.6M0.1%+111.10%
0
Increased
3.9M(+1.1%)$132.7M0.0%+160.34%
30

Showing 1-20 of 250

1 / 13
TEVATEVATEVA PHARMACEUTICAL-SP ADR

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used